On the buying side, ARK made a notable purchase of 17,386 shares of Coinbase Global Inc (PRE-REINCORPORATION) (NASDAQ:COIN) across its ARKK, ARKW, and ARKF ETFs, with a total dollar value of ...

It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Calling consciousness an "entropic engine" points to something psychologically obvious: selfhood costs energy. Maintaining a stable "me" model across time, contexts, and internal contradictions ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

Baystreet.ca News Commentary – Artificial intelligence and platform-based approaches reshaped cancer treatment development in ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

Smaller trades included the sale of 6,797 shares of Ibotta Inc (NASDAQ:IBTA) and 5,902 shares of Iridium Communications Inc (NASDAQ:IRDM), along with purchases in Caris Life Sciences Inc (NASDAQ:CAI) ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.